Gγ 10 inhibitors represent a class of chemical entities designed to specifically target and inhibit the function of Gγ 10, a member of the family of G protein gamma subunits. G proteins are heterotrimeric in nature, composed of alpha, beta, and gamma subunits, and they play a crucial role in transmitting signals from cell surface receptors to various intracellular pathways. The Gγ 10 subunit is associated with the G beta subunit, and together they form a complex that can influence the function of the G alpha subunit and its interaction with cell surface receptors. The inhibition of Gγ 10 can disrupt this signaling pathway, affecting the signal transduction processes mediated by G proteins. The specificity of Gγ 10 inhibitors lies in their ability to selectively interfere with the Gγ 10 subunit without affecting the myriad of other gamma subunits and their associated pathways.
Chemically, Gγ 10 inhibitors are typically small molecules that have been identified or designed through methods like high-throughput screening, computational modelling, and medicinal chemistry approaches. These compounds must possess the ability to bind with high affinity to the Gγ 10 subunit, often requiring the presence of particular pharmacophoric elements that can interact with unique amino acid residues or structural motifs of the protein. The interaction between Gγ 10 inhibitors and their target may involve a combination of non-covalent bonds, such as hydrogen bonds, ionic interactions, and hydrophobic contacts, which help to stabilize the inhibitor-Gγ 10 complex and prevent the Gγ 10 subunit from associating with its normal binding partners.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin ADP-ribosylates Gi, inhibiting its ability to interact with receptors. This action can indirectly affect Gγ 10 as part of the G-protein complex. | ||||||
NF 023 | 104869-31-0 | sc-204124 sc-204124A | 10 mg 50 mg | $161.00 $629.00 | 1 | |
A non-selective Gα inhibitor that can influence the activation of the entire G-protein complex, including Gγ 10. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
An antagonist of G-protein-coupled receptors, preventing their activation. This can indirectly influence the function of Gγ 10 as part of the broader G-protein signaling. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
Specific inhibitor of the Gq family of G-proteins. By inhibiting the function of Gq, it can indirectly affect signaling processes where Gγ 10 may be involved. | ||||||
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
It is a Gβγ signaling inhibitor, directly targeting the beta and gamma subunits of G-proteins, including potentially Gγ 10. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
It inhibits cytohesin exchange factors, impacting G-protein activation, and thus potentially affecting Gγ 10 signaling. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
An inhibitor of the Cdc42 GTPase, which can indirectly modulate G-protein-mediated signaling processes involving Gγ 10. | ||||||
FR 900359 | 107530-18-7 | sc-507357 | 500 µg | $226.00 | ||
Targets Gα subunits, preventing their activation. This action indirectly affects Gγ 10, which is part of the G-protein complex. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
An inhibitor of Trio RhoGEF, impacting RhoA and Rac1 GTPase signaling. This may indirectly modulate G-protein pathways associated with Gγ 10. | ||||||